Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) released its most recent quarterly report before the markets opened on Thursday. The pharma giant said that it had $0.94 in earnings per share (EPS) on $5.1 billion in revenue. Consensus estimates had called for $0.66 in EPS on $4.8 billion in revenue.
The same period of last year had $1.06 in EPS on $5.63 billion in revenue.Is This the Turnaround Teva Has Been Waiting For?
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться